bio2018-mybio-sessionicon-companypres

AbMax Biotechnology CO., LTD

1:00 PM–1:15 PM Jun 7, 2018

Theater 4, Level 0

Description

De-immunogenicity of Antibody Drug by Removing B Cell Epitope

Session ID: 22211

Tags